Screener
Wave Life Sciences WVE EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
FAQ
- What is Wave Life Sciences's EPS (diluted)?
- Wave Life Sciences (WVE) reported EPS (diluted) of -$0.34 in Q2 2026.
- How has Wave Life Sciences's EPS (diluted) changed year-over-year?
- Wave Life Sciences's EPS (diluted) decreased by 9.7% year-over-year, from -$0.31 to -$0.34.
- What is the long-term trend for Wave Life Sciences's EPS (diluted)?
- Over 3 years (2021 to 2025), Wave Life Sciences's EPS (diluted) has grown at a -20.1% compound annual growth rate (CAGR), from -$2.37 to -$1.21.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Wave Life Sciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude